This study presents solid evidence for distinct neurotransmitter release modalities between two subclasses of dopaminergic neurons in the olfactory bulb, highlighting an important finding that ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

We often think about diseases in terms of the symptoms they present. A cold might give you the sniffles or even GI distress, while malaria can give you fever, chills, or nausea, for example. These ...

We often think about diseases in terms of the symptoms they present. A cold might give you the sniffles or even GI distress, ...

Alcoholism is a progressive neurological disease in which adaptations in several neurotransmitter pathways ... Naltrexone is an opioid receptor antagonist that has been shown to reduce craving ...

Drinking coffee can either boost your mood or increase anxiety. While caffeine enhances dopamine and reduces stress, too much ...

Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 ...

Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...

This study identifies 47,350 enhancers active in human neurons during differentiation and links some to genes involved in ...

Researchers at the Center for Life Sciences at the Paul Scherrer Institute PSI have for the first time identified structural ...

Vasopressin — another neurotransmitter associated with relationships — and oxytocin also support social bonding in other species. Studies show that a surplus of vasopressin and oxytocin receptors — ...

Jan. 23, 2025 — The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and anti-anxiety medications in adolescents and young adults has ... Changes in Opioid Use Outcomes ...